ABSTRACT
Development of oral pharmaceutical drug products presentsmany technical and regulatory challenges. Speci¢cally, these include proper characterization of active pharmaceutical ingredient (API), assurance of compatibility of inactive ingredients with the active components over the shelf life of the product,processing andmanufacturing andquality controls and compliance with current federal regulations and draft Federal Regulations under the CFR provisions for comments and approval process at the Food and Drug Administration.
